🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/04/2015 8,00 8,02 7,80 7,91 -0,50% 2,75% 1.494.800
09/04/2015 7,97 8,04 7,83 7,95 -0,50% 2,63% 1.256.200
08/04/2015 7,84 8,02 7,77 7,99 +3,10% 3,19% 2.286.300
07/04/2015 7,64 7,91 7,62 7,75 +1,57% 3,80% 2.337.700
06/04/2015 7,59 7,79 7,37 7,63 +0,39% 5,47% 1.267.200
02/04/2015 7,38 7,86 7,21 7,60 +2,29% 8,81% 2.539.700
01/04/2015 6,73 7,44 6,60 7,43 +9,83% 12,44% 2.119.500
31/03/2015 6,94 7,04 6,68 6,77 -3,36% 5,19% 964.700
30/03/2015 7,05 7,18 6,83 7,00 +0,29% 4,96% 706.700
27/03/2015 6,76 7,03 6,76 6,98 +3,56% 4,02% 876.000
26/03/2015 6,83 6,88 6,50 6,74 -2,18% 5,56% 1.451.300
25/03/2015 7,16 7,20 6,85 6,89 -3,77% 4,89% 1.545.100
24/03/2015 7,10 7,38 7,05 7,16 +1,56% 4,65% 1.097.700
23/03/2015 7,27 7,35 6,77 7,05 -4,34% 7,98% 1.834.900
20/03/2015 7,82 7,90 7,35 7,37 -4,60% 7,03% 2.031.000
19/03/2015 7,68 7,88 7,56 7,73 +0,59% 4,17% 1.198.500
18/03/2015 7,51 7,74 7,42 7,68 +1,86% 4,26% 1.001.300
17/03/2015 7,40 7,64 7,34 7,54 +1,62% 3,99% 758.300
16/03/2015 7,54 7,58 7,26 7,42 -1,46% 4,24% 769.500
13/03/2015 7,56 7,63 7,24 7,53 -0,13% 5,16% 930.100
12/03/2015 7,61 7,77 7,41 7,54 -0,13% 4,73% 1.032.000
11/03/2015 7,31 7,58 7,21 7,55 +3,28% 5,06% 1.324.800
10/03/2015 7,36 7,47 7,15 7,31 -1,22% 4,28% 1.223.100
09/03/2015 7,77 7,82 7,34 7,40 -4,52% 6,18% 1.581.700
06/03/2015 7,83 8,01 7,70 7,75 -2,39% 3,96% 1.646.400
05/03/2015 8,30 8,36 7,61 7,94 +5,73% 9,04% 5.506.600
04/03/2015 7,14 7,53 7,02 7,51 +4,16% 7,14% 1.005.100
03/03/2015 7,26 7,32 6,86 7,21 -1,50% 6,34% 1.561.300
02/03/2015 7,49 7,51 6,91 7,32 -2,79% 8,01% 1.349.800
27/02/2015 7,73 7,75 7,44 7,53 -2,71% 4,08% 1.000.900